UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Carbapenem-Sparing Strategies for ESBL Producers: When and How

Antibiotics (Basel), 2020-02, Vol.9 (2), p.61

2020

Volltextzugriff (PDF)

Metallo-β-lactamases: a last frontier for β-lactams?

The Lancet infectious diseases, 2011-05, Vol.11 (5), p.381-393

2011

Volltextzugriff (PDF)

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients

Antibiotics (Basel), 2022-07, Vol.11 (8), p.1009

2022

Volltextzugriff (PDF)

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

European journal of clinical microbiology & infectious diseases, 2021, Vol.40 (1), p.219-224

2021

Volltextzugriff (PDF)

Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment

The Journal of infection, 2019-10, Vol.79 (4), p.312-321

2019

Volltextzugriff (PDF)

Antimicrobial Stewardship in the Hospital Setting: A Narrative Review

Antibiotics (Basel), 2023-10, Vol.12 (10), p.1557

2023

Volltextzugriff (PDF)

Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study

Viruses, 2024-08, Vol.16 (8), p.1241

2024

Volltextzugriff (PDF)

In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2395-2397

2011

Volltextzugriff (PDF)

Correction to: Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

BMC infectious diseases, 2019-03, Vol.19 (1), p.230-230, Article 230

2019

Volltextzugriff (PDF)

Evolution of epidemiological characteristics of infective endocarditis in Greece

International journal of infectious diseases, 2021-05, Vol.106, p.213-220

2021

Volltextzugriff (PDF)

Efficacy of Tigecycline Alone and in Combination with Gentamicin in the Treatment of Experimental Endocarditis Due to Linezolid-Resistant Enterococcus faecium

Antimicrobial Agents and Chemotherapy, 2013-07, Vol.57 (7), p.3392-3394

2013

Volltextzugriff (PDF)

Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections

Current opinion in infectious diseases, 2018-12, Vol.31 (6), p.566-577

2018

Volltextzugriff (PDF)

Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii : the significance of co-administration of rifampicin

International journal of antimicrobial agents, 2007-01, Vol.29 (1), p.51-55

2007

Volltextzugriff (PDF)

An update on the etiology and diagnostic evaluation of a leukemoid reaction

European journal of internal medicine, 2006-10, Vol.17 (6), p.394-398

2006

Volltextzugriff (PDF)

Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae

Journal of antimicrobial chemotherapy, 2006-05, Vol.57 (5), p.937-944

2006

Volltextzugriff (PDF)

Immunomodulatory Clarithromycin Treatment of Experimental Sepsis and Acute Pyelonephritis Caused by Multidrug-Resistant Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2004-01, Vol.48 (1), p.93-99

2004

Volltextzugriff (PDF)

Effects of Slime Produced by Clinical Isolates of Coagulase-Negative Staphylococci on Activities of Various Antimicrobial Agents

Antimicrobial Agents and Chemotherapy, 1998-04, Vol.42 (4), p.939-941

1998

Volltextzugriff (PDF)

Large vessel vasculitis in a patient with acute Q-fever: A case report

IDCases, 2014-01, Vol.1 (3), p.56-59

2014

Volltextzugriff (PDF)

Optimizing therapy in CRE infections

Current opinion in infectious diseases, 2018-10

2018

Volltextzugriff (PDF)

In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia

Antimicrobial Agents and Chemotherapy, 2001-06, Vol.45 (6), p.1860-1867

2001

Volltextzugriff (PDF)

Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016

Euro surveillance : bulletin européen sur les maladies transmissibles, 2018-08, Vol.23 (31), p.2

2018

Volltextzugriff (PDF)

Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatment

Journal of antimicrobial chemotherapy, 2020-10, Vol.75 (10), p.2852-2863

2020

Volltextzugriff (PDF)

Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa

BMC infectious diseases, 2006-02, Vol.6 (1), p.31-31, Article 31

2006

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Englisch
(123)
Japanisch
(11)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(64)
Science & Technology
(64)
Infectious Diseases
(50)
Pharmacology & Pharmacy
(41)
Biological And Medical Sciences
(36)
Microbiology
(36)
Medical Sciences
(34)
Pharmacology. Drug Treatments
(32)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(29)
Animals
(25)
Rabbits
(21)
Antibacterial Agents
(17)
Male
(16)
Microbial Sensitivity Tests
(14)
Anti-Bacterial Agents - Therapeutic Use
(13)
Antibiotics
(12)
Anti-Bacterial Agents - Pharmacology
(11)
Drug Resistance
(10)
Drug Resistance, Multiple, Bacterial
(10)
Anti-Bacterial Agents
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Carbapenem-Sparing Strategies for ESBL Producers: When and How

Metallo-β-lactamases: a last frontier for β-lactams?

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment

Antimicrobial Stewardship in the Hospital Setting: A Narrative Review

Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study

In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development

Correction to: Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

Evolution of epidemiological characteristics of infective endocarditis in Greece

Efficacy of Tigecycline Alone and in Combination with Gentamicin in the Treatment of Experimental Endocarditis Due to Linezolid-Resistant Enterococcus faecium

Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections

Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii : the significance of co-administration of rifampicin

An update on the etiology and diagnostic evaluation of a leukemoid reaction

Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae

Immunomodulatory Clarithromycin Treatment of Experimental Sepsis and Acute Pyelonephritis Caused by Multidrug-Resistant Pseudomonas aeruginosa

Effects of Slime Produced by Clinical Isolates of Coagulase-Negative Staphylococci on Activities of Various Antimicrobial Agents

Large vessel vasculitis in a patient with acute Q-fever: A case report

Optimizing therapy in CRE infections

In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia

Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016

Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatment

Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa

De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock

Aktive Filter

Suchergebnisse filtern